Patients
Rare Disease Day 2024 – The importance of shining a light on rare diseases
I have spent the last 15 years working in rare diseases, working with …
19739 items found
R&D
The opportunities and challenges facing rare disease therapies developers
To mark upcoming Rare Disease Day, pharmaphorum asked a panel of …
News
CSL, Travere close on EU approval of IgAN drug sparsentan
Travere Therapeutics and partner CSL Vifor could be weeks away from …
News
Bavarian Nordic gets swift EU review of chikungunya shot
Bavarian Nordic will get an accelerated review of its chikungunya …
News
AI improves adenoma detection in colonoscopies
An artificial intelligence-powered computer-aided detection (CAD) …
R&D
In search of the fabled tricorder
When two or more people from the world of medical technology meet, …
News
FDA will decide in June on Dupixent for COPD
The FDA has started a priority review of Sanofi and Regeneron’s …
News
After Roche’s exit, Blueprint passes Gavreto on to Rigel
Almost a year to the day after Roche pulled out a partnership on its …
R&D
This week in clinical trials: 29th January to 2nd February
Continuing our weekly clinical trial round-ups, here we look at …
R&D
Applying genetics to chemistry to find new small molecules
For all the advances that have been made in it, drug discovery is …
News
Aptar buys digital health partner Healint
More evidence of consolidation in the digital health category has …
News
Regeneron set for August FDA decision on BCMA bispecific
Regeneron’s bid to join the market for BCMA-targeted bispecific …
R&D
Viva in vivo: The next generation of cell therapy is fast ap...
Cell therapy is a field rife with innovation, but most of the novel therapies being developed fall into one of two basic categories: autologous cell therapies, which involve removing a pati
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
Access to genomic surveillance: Open science and public heal...
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
R&D
Partner Content
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
